Results 41 to 50 of about 76,888 (317)
Pharmaceuticals, 2021 Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics.
Valeria Catalani +6 more
doaj +1 more source
Head shops and new psychoactive substances: a public health perspective. [PDF]
, 2023 In 2010, Ireland found itself at the eye of an international storm as a network of head shops emerged selling new psychoactive substances (NPS) and Irish youth rapidly became the heaviest users of NPS in Europe.
Smyth, Bobby P
core +1 more source
Pharmaceuticals, 2022 Despite increasing reports, antidepressant (AD) misuse and dependence remain underestimated issues, possibly due to limited epidemiological and pharmacovigilance evidence.
Stefania Chiappini +5 more
doaj +1 more source
The International journal on drug policy, 2023 BACKGROUND The proliferation of Novel Psychoactive Substances (NPS) presents a challenge for global drug policy. The ease of online drug purchase and the emergence of the dark web have created new avenues for the growth of NPS.
Tayler Holborn, F. Schifano, P. Deluca
semanticscholar +1 more source
Novel psychoactive substances: a novel clinical challenge [PDF]
BMJ Case Reports, 2013 The recreational use of novel psychoactive substances in the UK has increased markedly within the last decade. The variety of new substances synthesised and sold as ‘legal’, often under the pretence of being ‘plant food’ or ‘bath salts’ is similarly increasing. This presents challenges to clinicians: they may be unaware of these substances or unable to
Christopher Daniel, Smith +2 more
openaire +2 more sources
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling [PDF]
, 2015 Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as
Liechti, Matthias E., Matthias Liechti
core +1 more source
What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs
Brain Sciences, 2020 Recently, a range of prescription and over-the-counter (OTC) drugs have emerged as being used recreationally, either on their own or in combination with other substances, both licit and illicit, including new psychoactive substances (NPS).
Stefania Chiappini, Fabrizio Schifano
doaj +1 more source
Analysing social media data to understand self-medication with novel psychoactive substances (NPS) [PDF]
, 2022 A content analysis using data from Reddit to explore self-medication practices with novel psychoactive substances ...
Tayler Holborn
core +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Novel Psychoactive Substances (NPS) profile in South Gloucestershire [PDF]
, 2014 Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause similar reactions to those produced by taking conventional drugs. The report estimates the prevalence of NPS use across South Gloucestershire.
Ismail, Nasrul
core +1 more source